|
|
|
|
Vol. 303, Issue 2, 520-526, November 2002
Department of Pharmacology, University of Bonn, Bonn, Germany
| |
Abstract |
|---|
|
|
|---|
In the search for P2-receptors modulating the stimulation-evoked
entry of calcium at processes of PC12 cells differentiated in the
presence of nerve growth factor and neurotrophin-3, electrically evoked
increases in free calcium were assessed by fura-2 microfluorimetry. Omission of calcium and addition of cadmium (100 µM) or the N-type calcium channel blocker
-conotoxin GVIA (0.5 µM) abolished or markedly reduced the evoked responses. The P2Y-receptor agonists 2-methylthio adenosine 5'-diphosphate (2-methylthio-ADP), ADP, and
adenosine 5'-O-(2-thiodiphosphate) (ADP
S) inhibited
the electrically evoked entry of calcium without any changes in basal
calcium concentrations. 2-Methylthio-ADP was the most potent agonist.
Adenosine,
P1,P4-di(adenosine-5')-tetraphosphate (Ap4A),
UDP, and UTP (30 µM each) had no effect. The effect of ADP
S (30 µM) was abolished by the P2-antagonists reactive blue 2 (3 µM),
suramin (100 µM), 2-methylthio-AMP (10 µM),
p-chloromercuriphenyl sulfonic acid (1 µM), and AR-C 69931MX
[N6-(2-methylthioethyl)-2-(3,3,3-trifluoropropylthio)-
,
-dichloromethylene adenosine 5'-triphosphate] (300 nM). In contrast,
pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (10 µM),
the selective P2Y1-receptor antagonist MRS 2179 (N6-methyl-2'-deoxyadenosine
3',5'-bisphosphate; 10 µM), as well as the adenosine
A1-receptor antagonist DPCPX
(8-cyclopentyl-1,3-dipropylxanthine; 100 nM), caused no change.
Pretreatment with pertussis toxin abolished the effect of ADP
S.
Reverse transcriptase-polymerase chain reaction revealed the presence
of mRNA for P2Y12-receptors in nondifferentiated and differentiated
PC12 cells. The results indicate that processes of differentiated PC12
cells possess P2Y12-receptors coupling to pertussis toxin-sensitive
G-proteins and mediating an inhibition of the stimulation-evoked entry
of calcium through
-conotoxin GVIA-sensitive calcium channels. This
suggests a role of P2Y12-receptors in neuromodulation in addition to
their involvement in platelet aggregation.
| |
Introduction |
|---|
|
|
|---|
The
operation of P2-receptors inhibiting the release of neurotransmitters
has been demonstrated in the peripheral and central nervous system (for
reviews see Silinsky et al., 1998
; Inoue et al., 1999
; von
Kügelgen et al., 1999a
). At postganglionic sympathetic axons the
receptors are activated by endogenous adenine nucleotides released as
cotransmitters of norepinephrine and, hence, mediate a negative
feedback inhibition of sympathetic transmitter release (Fuder and Muth,
1993
; von Kügelgen et al., 1993
). Release-inhibiting P2-receptors
have also been found in adrenal chromaffin cells and the cell bodies of
rat PC12 cells (Gandia et al., 1993
; Currie and Fox, 1996
; Powell et
al., 2000
; Vartian and Boehm, 2001
; Unterberger et al., 2002
). The
release-inhibiting P2-receptors share some properties with cloned and
expressed P2Y1-receptors (for references see above), but their
molecular identity is yet not known. In addition to inhibitory
P2-receptors, the cell bodies of postganglionic sympathetic neurons,
adrenal chromaffin cells, and PC12 cells possess excitatory
P2-receptors of distinct subtypes and with distinct signaling
transduction pathways (for reviews see Silinsky et al., 1998
; von
Kügelgen et al., 1999a
; for PC12 cells see, for example, Arslan
et al., 2000
; Unterberger et al., 2002
).
The inhibition of calcium channels at axon terminals is a key element
in the modulation of transmitter release by inhibitory G-protein-coupled receptors (see Przywara et al., 1993
; Mirotznik et
al., 2000
; Jarvis and Zamponi, 2001
). Therefore, we searched for
P2-receptors modulating the electrically evoked entry of calcium in
processes of differentiated PC12 cells. Effects of P2-receptor agonists
and antagonists on the electrically evoked increases in free calcium
concentration in these processes were assessed by means of fura-2
microfluorimetry to characterize P2-receptor subtypes in this model
system. A contribution of different calcium channels to the evoked
calcium entry and the possible involvement of pertussis toxin-sensitive
G-proteins were also analyzed. Moreover, we searched for the presence
of mRNA encoding for the recently cloned P2Y12-receptor in PC12 cells.
A part of the results has been presented at a meeting of the Federation
of the European Pharmacological Societies (Kulick and von
Kügelgen, 2001
).
| |
Materials and Methods |
|---|
|
|
|---|
Culturing.
PC12 cells (European Collection of Cell Cultures,
Salisbury, UK; original passage CB 2745) were cultured at 37°C and
5% CO2 in RPMI 1640 medium (11835; Invitrogen,
Karlsruhe, Germany) supplemented with 10% fetal bovine serum
(heat-inactivated; 10108; Invitrogen), 5% horse serum
(heat-inactivated; 26050; Invitrogen), 12.5 U/ml penicillin, and 12.5 µg/ml streptomycin (15140; Invitrogen). The cells were split once a
week by treating with trypsin-EDTA (0.5 g/l; 25300; Invitrogen) and
triturating with a fire-polished Pasteur pipette. Cells from passages 3 to 30 were used for further experiments. About 20,000 dissociated cells
in 50 µl of medium were poured onto coverslips (25 mm in diameter;
12-545-86; Fisher Scientific, Schwerte, Germany) coated first with
poly(L-lysine) (0.01%; P4707; Sigma Chemie, Schnelldorf,
Germany) and then with Matrigel Matrix (356234; BD Biosciences,
Bedford, MA). The coverslips were placed in a 35-mm culture dish
(Greiner, Solingen, Germany) and incubated for 30 to 45 min. Then
culture medium, 1.5 ml, was added. The medium (Dulbecco's modified
Eagle's medium/nutrient mixture F12, 1:1; 11039, Invitrogen)
was supplemented with N2 supplement (1×; 17502; Invitrogen), Glutamax
I (1×; 35050; Invitrogen), 25 U/ml penicillin, 25 µg/ml
streptomycin, and, to induce neuronal differentiation, 40 ng/ml nerve
growth factor-
(human, recombinant; N1408; Sigma), as well as 10 ng/ml neurotrophin-3 (human, recombinant; N1905; Sigma). The cells were
cultured for 6 to 18 days at 37°C, 5% CO2; medium was exchanged every 2 to 3 days.
fura-2 Microfluorimetry.
Cells cultured on coverslips were
incubated with fura-2 acetoxymethyl ester (fura-2 AM, 2 µM; F-1225;
Molecular Probes Europe, Leiden, Netherlands) for 30 min at 37°C. A
coverslip was then fixed in a superfusion chamber between two platinum
electrodes and mounted on the stage of a Zeiss Axiovert 100 microscope
equipped with an oil immersion F-Fluar 40× objective (Zeiss, Jena,
Germany). The cells were superfused at 1 ml/min and room temperature
with buffer containing 135 mM NaCl, 4.8 mM KCl, 1.3 mM
CaCl2, 1.2 mM KH2PO4, 10 mM glucose, and
10 mM HEPES (pH adjusted to 7.4 using NaOH).
KH2PO4 was omitted in
experiments with cadmium. After a presuperfusion period of 30 min,
fluorescence emission was measured after alternating excitation at 340 nm and 380 nm each applied for 5 to 9 ms and repeated every 1 s
using a Polychrome II monochromator, an Imago charge-coupled device
camera, and the TILLvisION imaging system (Till Photonics, Planeg,
Germany). Measurements were performed over processes (see Fig.
1A). One area in one process was
evaluated per cell. The portion of the coverslip depicted by the
charge-coupled device camera contained processes of one to three
individual cells. Preparations were stimulated by trains of 10 electrical pulses (p) at 100 Hz (200 mA, 0.3 ms; Stimulator II; Hugo
Sachs Elektronik-Harvard Apparatus GmbH, March-Hugstetten, Germany)
applied every 3 min. After three preceding periods of stimulation in
the absence of drugs, drugs were added to the buffer for 6 min. When
used, antagonists were given 18 min before the agonist. In the
intervals between stimulation periods, the cells were protected from
the excitation light to prevent bleaching and phototoxicity (see gaps
in the traces in Figs. 1C and 2).
|
|
Isolation of poly(A+) mRNA and RT-PCR.
mRNA was isolated from nondifferentiated and differentiated cells
cultured as described above, using the Oligotex Direct mRNA Mini Kit
(72022; QIAGEN GmbH, Hilden, Germany). The efficiency of the isolation
was proofed by the demonstration of mRNA for
-actin. Reverse
transcriptase-polymerase chain reaction (RT-PCR) was performed using
gene-specific primers for the rat P2Y12 receptor (sense primer:
CACCATGGAGGTGCCTGGTGCCAAC; antisense primer: CATTGGGGTCTCCTCGCTTGGGTC) and
-actin (sense: GTACCCCATTGAACACGGCATTG; antisense:
GTCACGCACGATTTCCCTCTCAG) and the Superscript One Step RT-PCR kit
(Invitrogen). Annealing temperature for the PCR reaction was 67.7°C
(30 cycles) in the case of the undifferentiated PC12 cells and 66°C
(45 cycles) in the case of the differentiated PC12 cells when
amplifying the mRNA for the P2Y12 receptor and
-actin. For control
experiments the enzyme reverse transcriptase was omitted (instead of
the RT-PCR enzyme mix, Taq Platinum Polymerase was used;
10966, Invitrogen). PCR products were analyzed by ethidium bromide
staining after agarose (0.9%) gel electrophoresis. The product of one
RT-PCR reaction with primers for the P2Y12 receptor was cloned into the expression vector pcDNA3.1D/V5-His-TOPO (Invitrogen). The sequence was
identified by cycle sequencing (Thermo Sequenase fluorescent labeled
primer cycle sequencing kit; Amersham Biosciences UK, Ltd., Little
Chalfont, Buckinghamshire, UK) using a LICOR Gene READIR 4200 sequencer
(MWG-Biotech, Ebersberg, Germany).
Materials.
The following drugs were used: adenosine
5'-triphosphate disodium (ATP), adenosine 5'-diphosphate sodium (ADP),
adenosine 5'-O-(2-thiodiphosphate) trilithium (ADP
S), 2-methylthio
adenosine 5'-diphosphate trisodium (2-methylthio-ADP), adenosine,
P1,P4-di(adenosine-5')-tetraphosphate
ammonium (Ap4A), uridine 5'-diphosphate sodium (UDP), uridine
5'-triphosphate trisodium (UTP),
N6-methyl 2'-deoxyadenosine
3',5'-bisphosphate diammonium (MRS 2179), 8-cyclopentyl-1,3-dipropylxanthine (DPCPX),
p-chloromercuriphenyl sulfonic acid (CMPS), 2-methylthio
adenosine 5'-monophosphate triethylammonium (2-methylthio-AMP),
pertussis toxin, nifedipine, cadmium chloride (Sigma),
-agatoxin IVa
(Bachem, Heidelberg, Germany),
-conotoxin GVIA (Alamone, Jerusalem,
Israel, or Bachem), N6-(2-methylthioethyl)-2-(3,3,3-trifluoropropylthio)-
,
-dichloromethylene adenosine 5'-triphosphate (AR-C 69931MX; Astra, Hässle,
Mölndal, Sweden), reactive blue 2 (RB2; Ega-Chemie, Steinheim,
Germany), suramin (Bayer, Leverkusen, Germany), and
pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (PPADS; Tocris
Cookson, Southampton, UK). Stock solutions of drugs were prepared with
distilled water or (nifedipine, CMPS, DPCPX) with dimethyl sulfoxide
(DMSO; Sigma). DMSO (0.01%) was added to the buffer used for control
experiments for nifedipine, CMPS, and DPCPX. For pertussis toxin
control experiments the solvents present in the purchased solution were
added to the medium [final concentration: 0.05% glycerol (Serva,
Heidelberg, Germany), 0.5 mM NaCl, 0.05 mM Trizma-Base (Sigma), and
0.38 mM glycine (Merck, Darmstadt, Germany)].
Statistics. Results are presented as means ± S.E. from n observations (evaluated processes; one process per analyzed cell). Except when stated otherwise, differences between means were tested for significance by Student's t test or (for multiple comparisons with the same control) by an analysis of variance (ANOVA) followed by the Bonferroni's multiple comparison test (Prism, GraphPad, San Diego CA). P < 0.05 or lower was the significance criterion.
| |
Results |
|---|
|
|
|---|
PC12 cells were plated on coverslips coated with
poly(L-lysine) and Matrigel and cultured in the presence of
nerve growth factor-
(40 ng/ml) and neurotrophin-3 (10 ng/ml) for up
to 18 days. After about 6 days in culture, the cells developed long and
multiple processes as shown in Fig. 1, A and B. fura-2 fluorescence was
measured as an estimate of changes in intracellular calcium concentration. After incubation with fura-2 AM, fluorescence was observed not only in cell bodies (not shown) but also in the processes (Fig. 1B). One area of one process was evaluated per cell (see marked
area in Fig. 1A). Electrical stimulation by square pulses (0.3 ms)
caused transient increases in the fura-2 fluorescence ratio (Fig. 1C)
dependent on the number of pulses applied (not shown). When the
preparations were stimulated by periods of 10 pulses/100 Hz applied
every 3 min, the responses were well reproducible (Fig. 1C). In the
absence of drugs, the response to a fourth period of stimulation
amounted to 106.9% of the averaged responses to the three preceding
periods (control; see legend to Table 1). On average, a preceding period of stimulation caused an increase in the
fura-2 fluorescence ratio by 64.0 ± 4.1% above baseline (n = 180).
|
Effects of Calcium Channel Blockers.
Omission of calcium from
the superfusion buffer abolished the response to electrical stimulation
(reduction by 92.6 ± 2.4%; n = 5;
P < 0.01). To study the contribution of
voltage-dependent calcium channels to the evoked increase in calcium
concentration, effects of several channel blockers were tested. Cadmium
(100 µM) as well as the N-type calcium channel blocker
-conotoxin GVIA (0.5 µM; Hirning et al., 1988
) markedly reduced the responses to
stimulation (Fig. 1C and Table 1), whereas the L-type calcium channel
blocker nifedipine (10 µM) and the P/Q-type calcium channel blocker
-agatoxin IVa (0.5 µM; Mintz et al., 1992
) failed to alter the
responses (Table 1). None of the compounds changed basal fluorescence
ratios (not shown).
Effects of Adenosine and Nucleotides.
Next, the effects of P1-
and P2-receptor agonists were analyzed. The P2Y-receptor agonist
ADP
S (Ralevic and Burnstock, 1998
) has previously been shown to
cause a preferential activation of presynaptic P2-receptors (see von
Kügelgen et al., 1999a
). When used in the present study on
processes of differentiated PC12 cells at a concentration of 30 µM,
ADP
S attenuated the electrically evoked responses by 51%, 2 min
after addition of the compound (Figs. 2A and
3). On average, the inhibitory effect of
ADP
S (30 µM) was smaller when the compound was present for an
additional period of 3 min (i.e., for two periods of stimulation;
inhibition by 34.4 ± 5.6%, n = 11;
P < 0.01, paired t test; e.g., Fig. 2A). For this reason, effects observed 2 min after addition of drugs were
analyzed in the present study. The inhibition by ADP
S was reversible
after removal of the compound from the superfusion buffer (Fig. 2A) and
dependent on the concentration used (Fig. 3). ADP and 2-methylthio-ADP,
agonists at the P2Y1-, P2Y12-, and P2Y13-receptors (von Kügelgen
and Wetter 2000
; Communi et al., 2001
; Hollopeter et al., 2001
; Zhang
et al., 2001
), also caused an inhibition of the electrically induced
increases in fura-2 fluorescence (Fig. 3). 2-Methylthio-ADP was the
most potent compound followed by ADP and ADP
S. In contrast to the
adenine nucleotides tested, both the diadenine nucleotide Ap4A, an
agonist at the rat P2Y2- and P2Y4-receptors (von Kügelgen and
Wetter, 2000
), and the P1-purinoceptor agonist adenosine failed to
change the electrically evoked responses (each compound tested at 30 µM; Fig. 3). The same was true for the uracil nucleotides UDP (30 µM; Fig. 3) and UTP (evoked response in the presence of 30 µM: 95.0 ± 2.4% of control, n = 7). UDP and UTP are
known to activate the P2Y2-, P2Y4-, and P2Y6-receptors (Nicholas et
al., 1996
). None of the compounds described above affected the basal
fluorescence ratio. However, ATP (30 µM), which activates
P2X-receptors in addition to P2Y-receptors (North and Barnard, 1997
;
Ralevic and Burnstock, 1998
; Nörenberg and Illes, 2000
),
increased the basal ratio by 49.5 ± 21.6% (n = 5, P < 0.01). This increase is likely to be due to a
P2X-receptor-mediated influx of calcium (see Arslan et al., 2000
;
Nörenberg and Illes, 2000
). ATP also tended to reduce the
electrically evoked responses in the present study on processes of PC12
cells, but the effect was not further analyzed due to the marked
increase in basal ratio, which makes the determination of electrically
evoked responses unreliable.
|
Interaction with Purinoceptor Antagonists.
Antagonists were
given 18 min before the agonist ADP
S (30 µM). DPCPX used at a
concentration (0.1 µM) about 200 times its affinity constant at the
adenosine A1-receptor (Lohse et al., 1987
) did
not affect the inhibitory action of ADP
S (Fig.
4). In contrast, reactive blue 2 (RB2, 3 µM) and suramin (100 µM), both of which block a number of
P2-receptor subtypes, abolished the inhibitory effect of ADP
S. The
P2-antagonist PPADS, known to effectively block P2Y1-receptors in
addition to several P2X-subtypes (Lambrecht, 2000
; von Kügelgen
and Wetter, 2000
), had no significant effect when used at a
concentration of 10 µM.
|
S. In contrast, CMPS (1 µM), 2-methylthio-AMP (10 µM), and AR-C 69931MX (300 nM), all of
which have been shown to block the recently cloned P2Y12-receptor (Hollopeter et al., 2001
S (Fig. 4). None of the antagonists themselves changed the
basal fluorescence ratio or the electrically evoked responses (not shown).
Effect of Treatment with Pertussis Toxin.
To analyze a
possible coupling of the inhibitory receptor to pertussis
toxin-sensitive G-proteins, cells were treated with pertussis toxin
(200 ng/ml) or its solvent for 16 to 22 h. Treatment with
pertussis toxin abolished the effect of ADP
S (Fig. 2B; Table 2) without any change in the basal
fluorescence ratio or the responses to the preceding periods of
stimulation (not shown).
|
Presence of mRNA for P2Y12-Receptors in PC12 Cells.
RT-PCR
with primers specific for the coding sequence of the rat P2Y12-receptor
revealed products of the expected length from two mRNA preparations of
nondifferentiated PC12 cells (not shown). Control reactions without the
enzyme reverse transcriptase showed no products, confirming that mRNA
but not genomic DNA acted as a template for the PCR reaction. Cycle
sequencing of one RT-PCR reaction product confirmed the identity of the
sequence with that of the cloned rat P2Y12-receptor (Hollopeter et al.,
2001
; GenBank accession code AF313450). When using three mRNA
preparations from differentiated PC12 cells cultured on coverslips in
the presence of nerve growth factor-
and neurotrophin-3 (see
Materials and Methods), similar results were obtained (Fig.
5).
|
| |
Discussion |
|---|
|
|
|---|
In the present study we searched for P2-receptors inhibiting the
influx of calcium via voltage-dependent calcium channels in processes
of differentiated PC12 cells. Changes in the concentration of calcium
in the processes were assessed by fura-2 microfluorimetry. Due to the
known problems of calibration (Leipziger et al., 1991
), fura-2
fluorescence ratios (F 340 nm/F 380 nm) instead of absolute concentrations of calcium were statistically evaluated.
Electrically Evoked Calcium Entry through N-Type Calcium
Channels.
Electrical field stimulation of the preparations induced
an influx of calcium in the processes through voltage-dependent calcium channels as shown by the blockade of the responses by either omission of calcium from the buffer or addition of cadmium to the buffer. The
evoked increase in calcium concentration was also markedly affected by
-conotoxin GVIA, but not by nifedipine or
-agatoxin IVa,
indicating that the increase was at least predominantly mediated by an
influx of calcium ions through N-type (Cav2.2;
Ertel et al., 2000
) calcium channels (for references, see above).
N-type calcium channels also play the predominant role in
stimulation-evoked calcium entry in postganglionic sympathetic neurons
(e.g., Hirning et al., 1988
; von Kügelgen et al., 1999b
). In
contrast, in adrenal chromaffin cells and cell bodies of PC12 cells,
L-type and P/Q-type channels are involved in addition to the N-type
channels in the evoked entry of calcium (Liu et al., 1996
; Lukyanetz
and Neher, 1999
).
Inhibitory P2Y12-Like Receptors Coupling to Pertussis
Toxin-Sensitive G-Proteins.
The present study demonstrates the
operation of P2Y12-like receptors inhibiting the electrically evoked
entry of calcium in processes of differentiated PC12 cells. The
preferential P2Y-receptor agonists ADP
S, ADP, and 2-methylthio-ADP
inhibited the evoked entry of calcium in a concentration-dependent
manner. The receptor involved in the inhibition of calcium entry at the
processes of PC12 cells is not an adenosine receptor, but a
P2-receptor, as shown by: 1) the lack of any effect of adenosine, 2)
the failure of the adenosine A1-receptor
antagonist DPCPX to alter the effect of ADP
S, and 3) the blockade of
the effect of ADP
S by several P2-receptor antagonists including the
selective P2Y-antagonist AR-C 69931MX. These findings also exclude an
involvement of the recently described heteromers of adenosine
A1-receptors and P2Y1-receptors (Yoshioka et al.,
2001
) or the putative P3-purinoceptors (Shinozuka et al., 1988
) since
both the heteromers, and P3-purinoceptors have been found to be
sensitive to the blockade by xanthine derivatives such as DPCPX.
S by the treatment of the cells with pertussis toxin indicates
that the receptors couple to Gi/o-proteins and
clearly identifies the receptors as P2Y-receptors. The lack of any
effect of UDP, UTP, and Ap4A excludes the involvement of P2Y2-, P2Y4-, and P2Y6-receptors (for review see Ralevic and Burnstock, 1998
S, ADP, and 2-methylthio-ADP is compatible with an
involvement of a diphosphate nucleotide preferring P2Y-receptor, i.e.,
the P2Y1-, P2Y12-, or P2Y13-receptor (Ralevic and Burnstock, 1998
S with the preferential P2Y1-receptor antagonist MRS 2179 (Boyer et al., 1998
S by
p-chloromercuriphenyl sulfonic acid and 2-methylthio-AMP, as well as AR-C 69931MX, used at a nanomolar concentration strongly suggests the characterization as P2Y12-receptor since these antagonists have previously been shown to block the cloned and expressed
P2Y12-receptor (Hollopeter et al., 2001
S, 2-methylthio-ADP, and ATP acted as agonists, whereas
uracil nucleotides were ineffective (for references, see the
introduction). Other common features are the blockade by the antagonists suramin and reactive blue 2 as well as by pretreatment with
pertussis toxin. Moreover, in a very recent study published during the
preparation of this article, the P2-receptors inhibiting adenylyl
cyclase activity in PC12 cells were characterized as P2Y12-receptors
(Unterberger et al., 2002Presence of mRNA for P2Y12-Receptors in PC12 Cells. In agreement with the idea that PC12 cells express P2Y12-receptors, RT-PCR experiments using poly(A+) mRNA preparations from nondifferentiated and differentiated PC12 cells showed the presence of mRNA for the full coding sequence of the P2Y12-receptor, compatible with an expression of these receptors in PC12 cells.
A Role for P2Y12-Receptors as Inhibitory Receptors in the Nervous
System?
P2Y12-receptors have been cloned from platelets
(Hollopeter et al., 2001
) and have been identified as one of the
P2-receptors involved in ADP-induced platelet aggregation (Hollopeter
et al., 2001
; Takasaki et al., 2001
; Zhang et al., 2001
). The present results suggest an additional functional role for P2Y12-receptors: a
role as inhibitory receptors operating at neuronal cells. Since mRNA
for P2Y12-receptors seems to be abundantly expressed in the brain
(Hollopeter et al., 2001
; Takasaki et al., 2001
; Zhang et al., 2001
),
the role of P2Y12-receptors as inhibitory receptors in the nervous
system may be widespread. A recent study using guanosine
5'-O-(3-[35S]thio)triphosphate
autoradiography on rat brain sections also showed evidence for the
operation of a receptor similar to the platelet ADP receptor in the
gray and white matter of the forebrain and brainstem (Laitinen et al.,
2001
).
| |
Conclusions |
|---|
|
|
|---|
The present study directly demonstrates the operation of inhibitory P2Y-receptors at neuronal processes. The receptors mediate an inhibition of the stimulation-evoked entry of calcium through N-type calcium channels. The properties of the receptors suggest a characterization as P2Y12-receptors.
| |
Acknowledgments |
|---|
We thank Prof. Dr. P. Illes (Rudolf-Boehm-Institut für Pharmakologie und Toxikologie, Universität Leipzig, Leipzig, Germany) and Prof. Dr. H. J. Ruoff (Bayer, Fachbereich Klinische Forschung, Wuppertal, Germany) for the supply of drugs.
| |
Footnotes |
|---|
Accepted for publication July 15, 2002.
Received for publication April 23, 2002.
This work was supported by the Doktor Robert Pfleger Stiftung (Bamberg, Germany).
DOI: 10.1124/jpet.102.037960
Address correspondence to: Ivar von Kügelgen, Department of Pharmacology, University of Bonn, Reuterstrasse 2b, D-53113 Bonn, Germany. E-mail: kugelgen{at}uni-bonn.de
| |
Abbreviations |
|---|
fura-2 AM, fura-2 acetoxymethyl ester;
F 340 nm/F 380 nm, ratio of fluorescence emission due to excitation at
340 nm/fluorescence emission due to excitation at 380 nm;
RT-PCR, reverse transcriptase-polymerase chain reaction;
ADP
S, adenosine
5'-O-(2-thiodiphosphate);
2-methylthio-ADP, 2-methylthio
adenosine 5'-diphosphate;
Ap4A, P1,P4-di(adenosine-5')-tetraphosphate;
MRS 2179, N6-methyl-2'-deoxyadenosine
3',5'-bisphosphate;
DPCPX, 8-cyclopentyl-1,3-dipropylxanthine;
CMPS, p-chloromercuriphenyl sulfonic acid;
2-methylthio-AMP, 2-methylthio adenosine 5'-monophosphate;
AR-C 69931MX, N6-(2-methylthioethyl)-2-(3,3,3-trifluoropropylthio)-
,
-dichloromethylene
adenosine 5'-triphosphate;
RB2, reactive blue 2;
PPADS, pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid;
DMSO, dimethyl
sulfoxide.
| |
References |
|---|
|
|
|---|
S autoradiography reveals a wide distribution of Gi/o-linked ADP receptors in the nervous system: close similarities with the platelet P2YADP receptor.
J Neurochem
77:
505-518[CrossRef][Medline].
a selective high affinity antagonist radioligand for A1 adenosine receptors.
Naunyn-Schmiedeberg's Arch Pharmacol
336:
204-210[CrossRef][Medline].This article has been cited by other articles:
![]() |
K. Hoffmann, Y. Baqi, M. S. Morena, M. Glanzel, C. E. Muller, and I. von Kugelgen Interaction of New, Very Potent Non-Nucleotide Antagonists with Arg256 of the Human Platelet P2Y12 Receptor J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 648 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Morrell, H. Sun, M. Ikeda, J.-C. Beique, A. M. Swaim, E. Mason, T. V. Martin, L. E. Thompson, O. Gozen, D. Ampagoomian, et al. Glutamate mediates platelet activation through the AMPA receptor J. Exp. Med., March 17, 2008; 205(3): 575 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Ennion, A. D. Powell, and E. P. Seward Identification of the P2Y12 Receptor in Nucleotide Inhibition of Exocytosis from Bovine Chromaffin Cells Mol. Pharmacol., September 1, 2004; 66(3): 601 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Gerevich, S. J. Borvendeg, W. Schroder, H. Franke, K. Wirkner, W. Norenberg, S. Furst, C. Gillen, and P. Illes Inhibition of N-Type Voltage-Activated Calcium Channels in Rat Dorsal Root Ganglion Neurons by P2Y Receptors Is a Possible Mechanism of ADP-Induced Analgesia J. Neurosci., January 28, 2004; 24(4): 797 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Queiroz, C. Talaia, and J. Goncalves ATP Modulates Noradrenaline Release by Activation of Inhibitory P2Y Receptors and Facilitatory P2X Receptors in the Rat Vas Deferens J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 809 - 815. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||